Rab Geranylgeranyltransferase Subunit Beta as a Potential Indicator to Assess the Progression of Amyotrophic Lateral Sclerosis

Background: Currently, there is no effective treatment for amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disorder. Many biomarkers have been proposed, but because ALS is a clinically heterogeneous disease with an unclear etiology, biomarker discovery for ALS has been challengi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jing, Xin, Cheng, Huo, Jia, Li, Xin, Dong, Hui, Liu, Qi, Li, Rui, Liu, Yaling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670085/
https://www.ncbi.nlm.nih.gov/pubmed/38002490
http://dx.doi.org/10.3390/brainsci13111531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670085/
https://www.ncbi.nlm.nih.gov/pubmed/38002490
http://dx.doi.org/10.3390/brainsci13111531

Ejemplares similares